Live feed
Filing
SC 13D
SC 13D0001829126-23-006440·Sire Group Ltd.
Schedule 13D ownership disclosure
TITAN PHARMACEUTICALS INC
Security class unavailable
Event date: 2023-09-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 16.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001829126-23-006440
- Form type
- SC 13D
- Filer
- Sire Group Ltd.
- CIK
- CIK 1995392
- Filed
- Oct 04, 2023
- Reporting period
- Sep 13, 2023
- Description
- Schedule 13D beneficial ownership